|
Peter C. Alain joined Aastrom in August 2007 as Senior Director, Quality Assurance. Mr. Alain has more than 25 years of Quality Assurance (QA) experience in the domestic and international pharmaceutical industries, including GMP/GLP/GCP compliance from drug discovery through post marketing. Prior to joining Aastrom, Mr. Alain held several management level positions at Pfizer, Inc., formerly Warner-Lambert/Parke-Davis, for over 26 years. Most recently, he was the Worldwide Development Quality Assurance Head for the U.S. and Latin America region within Pfizer's Global Research and Development division. During his career, he has been a member of PhRMA's Bioresearch Monitoring Steering Committee, coordinated, facilitated and mediated more than 10 successful domestic and international regulatory agency inspections, established the GMP Roundtable Forum for the production of clinical supplies and established one of the first industry QA groups to ensure electronic data integrity across GMP/GLC/GCP regulated areas. Mr. Alain received a B.S. in Biology from the University of Toronto, Canada. | 